Hangzhou Fuluo Biological Technology Co.,Ltd. 
                             
Product Detail
Moxifloxacin hcl
Detail

Moxifloxacin hcl

Other name: AVALOX; BAY-12-8039; ACTIRA; PROFLOX; MOXIFLOXACIN HCl

CAS No.: 186826-86-8

Assay: 98.0~102.0%

Packing: 1kg/tin; 25kg/drum

M. F.: C21H25ClFN3O4

M. W.: 437.89

Appearance: Light yellow powder


Introduction:

Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG (initially called BAY 12-8039). It is marketed worldwide (as the hydrochloride) under the brand names Avelox, Avalox, and Avelon for oral treatment. In most countries, the drug is also available in parenteral form for intravenous infusion. Moxifloxacin is also sold in an ophthalmic solution (eye drops) under the brand names Vigamox, and Moxeza for the treatment of conjunctivitis (pink eye). Its antibacterial spectrum includes enteric Gram-() rods (Escherichia coli, Proteus species, Klebsiella species), Haemophilus influenzae, atypical bacteria (Mycoplasma, Chlamydia, Legionella), and Streptococcus pneumoniae, and anaerobic bacteria. It differs from earlier antibacterials of the fluoroquinolone class such as levofloxacin and ciprofloxacin in having greater activity against Gram-positive bacteria and anaerobes. Because of its potent activity against the common respiratory pathogen Streptococcus pneumoniae, it is considered a "respiratory quinolone."


Uses:

Moxifloxacin is used to treat a number of infections, including: respiratory tract infections, cellulitis, anthrax, intraabdominal infections, endocarditis, meningitis, and tuberculosis.